Snider Lindy 4
4 · NEXIEN BIOPHARMA, INC. · Filed Jun 7, 2021
Insider Transaction Report
Form 4
Snider Lindy
Director
Transactions
- Award
Common stock
2021-06-07+250,000→ 730,000 total
Holdings
- 100,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2023-07-25→ Common stock (100,000 underlying)
Footnotes (1)
- [F1]These shares were issued as compensation for service as a director.